Academic Jobs Logo

Rate My Professor Iffat Quaes Chowdhury

University of Development Alternative

Manage Profile
5.00/5 · 1 review
5 Star1
4 Star0
3 Star0
2 Star0
1 Star0
5.05/4/2026

Always approachable and supportive.

About Iffat

Professor Dr. Iffat Quaes Chowdhury holds the position of Professor in the Department of Pharmacy at the University of Development Alternative (UODA), a private university located in Dhaka, Bangladesh. She earned her Ph.D. in Microbiology from the Université de Science et Technologie de Lille-I, France. Her specified academic interest is Pharmaceutical Microbiology, aligning her expertise with key areas in pharmaceutical sciences where microbiological principles are applied to drug development, quality control, and safety. In addition to her faculty role, Dr. Chowdhury serves as the Registrar of UODA, a senior administrative appointment responsible for overseeing student admissions, academic records, examinations, and regulatory compliance within the institution.

Dr. Chowdhury has made contributions to recent scholarly literature in pharmacy through co-authorship on several publications focusing on emerging technologies and therapeutic innovations. Among her key works is 'Artificial Intelligence in Pharmacy: Innovations, Applications and Future Emerging Challenges' published in 2024, co-authored with Al Amin, Rodshi Abyaz, Abul Kalam Azad, and others, which examines AI's transformative potential in pharmaceutical practices. Another publication, 'The Journey of Industrial Revolutions and the Rise of AI in Pharmaceutical Manufacturing' (2025), details the evolution of industrial processes and AI integration in production, with co-authors including Sanzida Siam, Rodshi Abyaz, and Abul Kalam Azad. She also co-authored 'Unveiling the Fountain of Youth: A Review of Chronological Journey from Ancient Folklore to Modern Anti-Aging Science' (2024), exploring historical and contemporary anti-aging research; 'Regenerative Medicine: A Broad Analysis of Innovations and Therapeutic Applications' (2025); and 'Approved Medicinal Plants with Anticancer Properties: A Comprehensive Review' (2025). Additional contributions appear in journals such as the International Journal of Progressive Research in Engineering Management and Science. These publications underscore her active participation in multidisciplinary pharmacy research addressing AI, manufacturing advancements, regenerative medicine, and natural product therapeutics.